Our results have demonstrated that among children with ALL, homozygous carriers TYMS 6bp deletion, were more than four times more likely to experience grade 2 or higher GIT toxicity than the non-HR patients with other genotypes. Here, TYMS is linked to acute lymphoblastic leukemia.